This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fatoohi, A. F. Articles by Peyron, F. Search for Related Content PubMed PubMed Citation Articles by Fatoohi, A. F. Articles by Peyron, F.

Cellular Immune Responses to Recombinant Antigens in Pregnant Women Chronically Infected with Toxoplasma gondii

E. A. 3087 Parasitologie, Faculté de Médecine Lyon Nord,¹ Laboratoire de Parasitologie and Laboratoire d'Immunologie, Hôpital de la Croix-Rousse,² Laboratoire d'Immunologie et de Biologie Pulmonaire, Hôpital Louis Pradel,³ Laboratoire d'Immunologie Centre Hospitalier Lyon Sud, Lyon, France⁴

Received 27 November 2001/ Accepted 15 February 2002

The parasite Toxoplasma gondii can infect most mammals and birds, sometimes causing severe pathology. Primary infection during pregnancy can result in abortion or fetal defects. Host immunity, particularly cellular immunity towards antigenic peptides, can control infection, but an efficient vaccine is not yet available. We have evaluated T-cell responses to a crude soluble toxoplasma antigen (ST-Ag) and to five recombinant peptide antigens of cells in whole-blood cultures from 22 pregnant women with preexisting infections and from 7 pregnant negative controls. Cells from all infected patients but from none of the controls responded specifically to ST-Ag by expressing surface CD25 on culture. Responses to the recombinant antigens showed considerable variation between individuals. rGRA1 elicited a response in 16 of the 22 samples (73%), rSAG1 in 13, rGRA7 in 9, rGRA6-CT in 4, and rGRA6-NT in only 1. Most responding cells were CD4⁺. Cells from infected subjects cultured with ST-Ag all released high levels of gamma interferon (IFN-) into the culture supernatant (4,343 ± 2,536 pg/ml). Cells from 12 patients released IFN- after culture with rGRA1 (130 ± 98 pg/ml), those from 10 patients released it after culture with rSAG1 (183 ± 128 pg/ml), and those from 4 patients released it after culture with rGRA7 (324 ± 374 pg/ml). Intensity of IFN- production in response to the latter two recombinant antigens correlated with responses to ST-Ag (r = 0.61 and 0.53, respectively; P < 0.01). Interleukin-4 was always absent from supernatants of cells stimulated with toxoplasma antigens. The heterogeneity of human responses to individual recombinant toxoplasma antigens should be considered in the design of potential vaccines.

This article has been cited by other articles:

• Kim, S.-K., Boothroyd, J. C. (2005). Stage-Specific Expression of Surface Antigens by Toxoplasma gondii as a Mechanism to Facilitate Parasite Persistence. J. Immunol. 174: 8038-8048 [Abstract] [Full Text]  
• Martin, V., Supanitsky, A., Echeverria, P. C., Litwin, S., Tanos, T., De Roodt, A. R., Guarnera, E. A., Angel, S. O. (2004). Recombinant GRA4 or ROP2 Protein Combined with Alum or the gra4 Gene Provides Partial Protection in Chronic Murine Models of Toxoplasmosis. CVI 11: 704-710 [Abstract] [Full Text]  
• Scorza, T., D'Souza, S., Laloup, M., Dewit, J., De Braekeleer, J., Verschueren, H., Vercammen, M., Huygen, K., Jongert, E. (2003). A GRA1 DNA Vaccine Primes Cytolytic CD8+ T Cells To Control Acute Toxoplasma gondii Infection. Infect. Immun. 71: 309-316 [Abstract] [Full Text]